Mosaic vessel and VM channel formation in a B16F10 mouse melanoma model are reduced by thalidomide which inhibits expression of VEGF, NFκB, PCNA, MMP-2 and MMP-9 [387]. The gene discussed is VEGFA; the disease is melanoma.